(R)-3-(tert-Butyl)-4-(2,6-diphenoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 250mg

(4-Fluoro-3-(propylcarbamoyl)phenyl)boronic acid, 95.0%, 1g

2-(2-Dimethylaminoethyl)-5-methyl-2H-pyrazol-3-ylamine, 98%, 250mg

(E)-2-CYCLOPROPYLVINYLBORONIC ACID PINACOL ESTER, 95.0%, 5g

2-(1-(tert-Butoxycarbonyl)-3-oxopiperazin-2-yl)acetic acid, 95.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)propanoic acid, 95+%, 5g

2-Bromo-3-hydroxymethyl-thiophene, 95.0%, 5g

1-(1,1'-Biphenyl-4-yl)-2-chloroethanone, 97.0%, 100g

(3-(Hydroxymethyl)phenyl)(imino)(methyl)-l6-sulfanone, 250mg

Ethyl Heptadecanoate, 97%, 25g

3-metil-2-benzotiazolinona hidrazona, clorhidrato, mínimo 98 %, pa, 10 g, envase de vidrio

4-Aminophthalic Acid>95.0%(T)25g

2-Amino-4-(tert-butyl)thiazole-5-carbonitrile, 97%, 5g